Annual CAPEX
$390.30 K
+$60.90 K+18.49%
31 December 2022
Summary:
Navidea Biopharmaceuticals annual capital expenditures is currently $390.30 thousand, with the most recent change of +$60.90 thousand (+18.49%) on 31 December 2022. During the last 3 years, it has fallen by -$23.60 thousand (-5.70%). NAVB annual CAPEX is now -92.01% below its all-time high of $4.89 million, reached on 31 December 1997.NAVB CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
N/A
30 September 2023
Summary:
Navidea Biopharmaceuticals quarterly capital expenditures is not available.NAVB Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
N/A
30 September 2023
Summary:
Navidea Biopharmaceuticals TTM capital expenditures is not available.NAVB TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NAVB CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | -5.7% | - | - |
| 5 y5 years | +744.8% | - | - |
NAVB CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -5.7% | +18.5% | ||||
| 5 y | 5 years | -5.7% | +744.8% | ||||
| alltime | all time | -92.0% | >+9999.0% |
Navidea Biopharmaceuticals CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | $390.30 K(+18.5%) | $72.00 K(-8.7%) | $390.30 K(-4.3%) |
| Sept 2022 | - | $78.90 K(-34.9%) | $407.70 K(-11.8%) |
| June 2022 | - | $121.20 K(+2.5%) | $462.00 K(+21.5%) |
| Mar 2022 | - | $118.20 K(+32.2%) | $380.10 K(+15.4%) |
| Dec 2021 | $329.40 K(-20.4%) | $89.40 K(-32.9%) | $329.40 K(+2.1%) |
| Sept 2021 | - | $133.20 K(+238.9%) | $322.60 K(-18.7%) |
| June 2021 | - | $39.30 K(-41.8%) | $397.00 K(-4.8%) |
| Mar 2021 | - | $67.50 K(-18.3%) | $416.90 K(+0.7%) |
| Dec 2020 | $413.90 K(+630.0%) | $82.60 K(-60.2%) | $413.80 K(+24.9%) |
| Sept 2020 | - | $207.60 K(+250.7%) | $331.20 K(+168.0%) |
| June 2020 | - | $59.20 K(-8.1%) | $123.60 K(+91.9%) |
| Mar 2020 | - | $64.40 K(+139.4%) | $64.40 K(+39.1%) |
| Dec 2019 | $56.70 K(+22.7%) | - | - |
| Dec 2018 | $46.20 K(+37.1%) | $26.90 K(+66.0%) | $46.30 K(+113.4%) |
| Sept 2018 | - | $16.20 K(+406.3%) | $21.70 K(-24.4%) |
| June 2018 | - | $3200.00(+39.1%) | $28.70 K(-14.8%) |
| Dec 2017 | $33.70 K(+1772.2%) | $2300.00(-90.1%) | $33.70 K(+7.3%) |
| Sept 2017 | - | $23.20 K(+182.9%) | $31.40 K(+282.9%) |
| June 2017 | - | $8200.00(>+9900.0%) | $8200.00(+355.6%) |
| Dec 2016 | $1800.00(-97.3%) | $0.00(0.0%) | $1800.00(-82.7%) |
| Sept 2016 | - | $0.00(0.0%) | $10.40 K(-65.7%) |
| June 2016 | - | $0.00(-100.0%) | $30.30 K(-51.4%) |
| Mar 2016 | - | $1800.00(-79.1%) | $62.30 K(-5.7%) |
| Dec 2015 | $66.10 K(-94.5%) | $8600.00(-56.8%) | $66.10 K(-23.0%) |
| Sept 2015 | - | $19.90 K(-37.8%) | $85.80 K(-19.6%) |
| June 2015 | - | $32.00 K(+471.4%) | $106.70 K(-47.8%) |
| Mar 2015 | - | $5600.00(-80.2%) | $204.60 K(-82.8%) |
| Dec 2014 | $1.19 M(-7.8%) | $28.30 K(-30.6%) | $1.19 M(-28.4%) |
| Sept 2014 | - | $40.80 K(-68.6%) | $1.66 M(-3.6%) |
| June 2014 | - | $129.90 K(-86.9%) | $1.73 M(-10.5%) |
| Mar 2014 | - | $992.60 K(+98.0%) | $1.93 M(+49.2%) |
| Dec 2013 | $1.29 M(+92.4%) | $501.20 K(+390.4%) | $1.29 M(+54.0%) |
| Sept 2013 | - | $102.20 K(-69.2%) | $839.30 K(-14.6%) |
| June 2013 | - | $332.10 K(-6.9%) | $982.60 K(+10.8%) |
| Mar 2013 | - | $356.90 K(+642.0%) | $887.20 K(+32.1%) |
| Dec 2012 | $671.80 K(+184.3%) | $48.10 K(-80.4%) | $671.70 K(-5.6%) |
| Sept 2012 | - | $245.50 K(+3.7%) | $711.80 K(+34.3%) |
| June 2012 | - | $236.70 K(+67.4%) | $530.00 K(+67.5%) |
| Mar 2012 | - | $141.40 K(+60.3%) | $316.40 K(+33.9%) |
| Dec 2011 | $236.30 K(-40.7%) | $88.20 K(+38.5%) | $236.30 K(+30.8%) |
| Sept 2011 | - | $63.70 K(+175.8%) | $180.60 K(-16.9%) |
| June 2011 | - | $23.10 K(-62.3%) | $217.20 K(-39.1%) |
| Mar 2011 | - | $61.30 K(+88.6%) | $356.80 K(-10.5%) |
| Dec 2010 | $398.70 K(+137.7%) | $32.50 K(-67.6%) | $398.80 K(+1.5%) |
| Sept 2010 | - | $100.30 K(-38.4%) | $393.10 K(+25.2%) |
| June 2010 | - | $162.70 K(+57.5%) | $314.10 K(+44.1%) |
| Mar 2010 | - | $103.30 K(+285.4%) | $217.90 K(+29.9%) |
| Dec 2009 | $167.70 K(+25.3%) | $26.80 K(+25.8%) | $167.80 K(+2.6%) |
| Sept 2009 | - | $21.30 K(-68.0%) | $163.50 K(-18.2%) |
| June 2009 | - | $66.50 K(+25.0%) | $199.80 K(+16.8%) |
| Mar 2009 | - | $53.20 K(+136.4%) | $171.00 K(+27.7%) |
| Dec 2008 | $133.80 K(+178.8%) | $22.50 K(-60.9%) | $133.90 K(+14.8%) |
| Sept 2008 | - | $57.60 K(+52.8%) | $116.60 K(+83.0%) |
| June 2008 | - | $37.70 K(+134.2%) | $63.70 K(+85.2%) |
| Mar 2008 | - | $16.10 K(+209.6%) | $34.40 K(-28.2%) |
| Dec 2007 | $48.00 K | $5200.00(+10.6%) | $47.90 K(-67.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2007 | - | $4700.00(-44.0%) | $146.60 K(-13.4%) |
| June 2007 | - | $8400.00(-71.6%) | $169.30 K(-6.2%) |
| Mar 2007 | - | $29.60 K(-71.5%) | $180.50 K(+3.0%) |
| Dec 2006 | $175.20 K(+64.4%) | $103.90 K(+279.2%) | $175.20 K(+63.9%) |
| Sept 2006 | - | $27.40 K(+39.8%) | $106.90 K(+2.0%) |
| June 2006 | - | $19.60 K(-19.3%) | $104.80 K(-1.3%) |
| Mar 2006 | - | $24.30 K(-31.7%) | $106.20 K(-0.4%) |
| Dec 2005 | $106.60 K(+21.3%) | $35.60 K(+40.7%) | $106.60 K(+16.4%) |
| Sept 2005 | - | $25.30 K(+20.5%) | $91.60 K(+1.0%) |
| June 2005 | - | $21.00 K(-15.0%) | $90.70 K(-6.1%) |
| Mar 2005 | - | $24.70 K(+19.9%) | $96.60 K(+9.9%) |
| Dec 2004 | $87.90 K(+16.4%) | $20.60 K(-15.6%) | $87.90 K(+10.4%) |
| Sept 2004 | - | $24.40 K(-9.3%) | $79.60 K(-22.5%) |
| June 2004 | - | $26.90 K(+68.1%) | $102.70 K(+23.7%) |
| Mar 2004 | - | $16.00 K(+30.1%) | $83.00 K(+9.9%) |
| Dec 2003 | $75.50 K(-71.3%) | $12.30 K(-74.1%) | $75.50 K(-11.8%) |
| Sept 2003 | - | $47.50 K(+559.7%) | $85.60 K(-24.6%) |
| June 2003 | - | $7200.00(-15.3%) | $113.50 K(-53.1%) |
| Mar 2003 | - | $8500.00(-62.1%) | $242.20 K(-7.9%) |
| Dec 2002 | $263.00 K(+265.3%) | $22.40 K(-70.3%) | $263.00 K(+1.1%) |
| Sept 2002 | - | $75.40 K(-44.5%) | $260.10 K(+33.3%) |
| June 2002 | - | $135.90 K(+363.8%) | $195.10 K(+119.7%) |
| Mar 2002 | - | $29.30 K(+50.3%) | $88.80 K(+23.2%) |
| Dec 2001 | $72.00 K(-57.2%) | $19.50 K(+87.5%) | $72.10 K(-18.0%) |
| Sept 2001 | - | $10.40 K(-64.9%) | $87.90 K(-50.6%) |
| June 2001 | - | $29.60 K(+134.9%) | $178.00 K(+5.5%) |
| Mar 2001 | - | $12.60 K(-64.3%) | $168.70 K(+0.3%) |
| Dec 2000 | $168.20 K(+123.1%) | $35.30 K(-64.9%) | $168.20 K(+26.6%) |
| Sept 2000 | - | $100.50 K(+395.1%) | $132.90 K(+310.2%) |
| June 2000 | - | $20.30 K(+67.8%) | $32.40 K(+167.8%) |
| Mar 2000 | - | $12.10 K(>+9900.0%) | $12.10 K(-99.4%) |
| Dec 1999 | $75.40 K(-97.9%) | - | - |
| June 1999 | - | $0.00(-100.0%) | $2.17 M(-15.6%) |
| Mar 1999 | - | $100.00 K(-92.1%) | $2.57 M(-30.0%) |
| Dec 1998 | $3.67 M(-24.9%) | $1.27 M(+58.5%) | $3.67 M(+15.1%) |
| Sept 1998 | - | $800.00 K(+100.0%) | $3.19 M(-18.0%) |
| June 1998 | - | $400.00 K(-66.7%) | $3.89 M(-26.5%) |
| Mar 1998 | - | $1.20 M(+52.4%) | $5.29 M(+8.2%) |
| Dec 1997 | $4.89 M(+35.8%) | $787.60 K(-47.5%) | $4.89 M(-114.3%) |
| Sept 1997 | - | $1.50 M(-16.7%) | -$34.20 M(-651.6%) |
| June 1997 | - | $1.80 M(+125.0%) | $6.20 M(+113.8%) |
| Mar 1997 | - | $800.00 K(-102.1%) | $2.90 M(-19.4%) |
| Dec 1996 | $3.60 M(+157.1%) | -$38.30 M(-191.4%) | $3.60 M(-91.4%) |
| Sept 1996 | - | $41.90 M(-2893.3%) | $41.90 M(>+9900.0%) |
| June 1996 | - | -$1.50 M(-200.0%) | $0.00(-100.0%) |
| Mar 1996 | - | $1.50 M(+7.1%) | $1.50 M(+7.1%) |
| Dec 1995 | $1.40 M(0.0%) | - | - |
| Dec 1994 | $1.40 M(+250.0%) | $1.40 M(-187.5%) | $1.40 M(-110.2%) |
| Sept 1994 | - | -$1.60 M(<-9900.0%) | -$13.70 M(-785.0%) |
| June 1994 | - | $0.00(-100.0%) | $2.00 M(-137.7%) |
| Mar 1994 | - | $1.60 M(-111.7%) | -$5.30 M(-1425.0%) |
| Dec 1993 | $400.00 K(+300.0%) | -$13.70 M(-197.2%) | $400.00 K(-97.2%) |
| Sept 1993 | - | $14.10 M(-293.2%) | $14.10 M(>+9900.0%) |
| June 1993 | - | -$7.30 M(-200.0%) | $0.00(-100.0%) |
| Mar 1993 | - | $7.30 M | $7.30 M |
| Dec 1992 | $100.00 K | - | - |
FAQ
- What is Navidea Biopharmaceuticals annual capital expenditures?
- What is the all time high annual CAPEX for Navidea Biopharmaceuticals?
- What is the all time high quarterly CAPEX for Navidea Biopharmaceuticals?
- What is the all time high TTM CAPEX for Navidea Biopharmaceuticals?
What is Navidea Biopharmaceuticals annual capital expenditures?
The current annual CAPEX of NAVB is $390.30 K
What is the all time high annual CAPEX for Navidea Biopharmaceuticals?
Navidea Biopharmaceuticals all-time high annual capital expenditures is $4.89 M
What is the all time high quarterly CAPEX for Navidea Biopharmaceuticals?
Navidea Biopharmaceuticals all-time high quarterly capital expenditures is $41.90 M
What is the all time high TTM CAPEX for Navidea Biopharmaceuticals?
Navidea Biopharmaceuticals all-time high TTM capital expenditures is $41.90 M